Overview
- 26 inspections across 25 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-05.
At a glance
Inspections
26
Sites
25
Observations
0
Career since
Mar 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Thermo Fisher Biopharma Services PTE. LTD | 5 May 2026 | Human Drugs | On file |
| Q-Med AB | 27 Mar 2026 | Human Drugs | On file |
| Allergan Sales, LLC | 7 Nov 2025 | Human Drugs | On file |
| DR. REDDY'S LABORATORIES LTD | 12 Sep 2025 | Human Drugs | On file |
| GlaxoSmithKline Manufacturing S.p.A. | 15 May 2025 | Human Drugs | On file |
Sites inspected
Thermo Fisher Biopharma Services PTE. LTDSingapore, Singapore1 insp.
Q-Med ABUppsala, Sweden1 insp.
Allergan Sales, LLCIrvine, United States1 insp.
DR. REDDY'S LABORATORIES LTDBachupally, India1 insp.
GlaxoSmithKline Manufacturing S.p.A.Torrile, Italy1 insp.
Co-investigators
Investigators who share inspections with this person.
Hamet M Toure3 shared
Olumide A Martins2 shared
Ying Zhang2 shared
Maria G Gutierrez-Hoffman2 shared
Thuy T Nguyen2 shared
Qibing Zhou1 shared
Jun Liu1 shared
Md Kamal Hossain1 shared
Baikuntha Aryal1 shared
Priscilla A Amador Do Amaral1 shared
Full investigator report
Get the verbatim findings behind Madushini N Dharmasena's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site